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Using the Western blot method with an epidermal extract as substrate it was found that
normal human serum contains a large numher of antihodies which, using this method, react with
epidermal antigens. A similar observation was made using normal human serum in an indirect
immunofluorescence system with normal human skin as substrate.^
Some of the lines seen on Western blot disappear when the serum is adsorbed onto a
culturable micro-organism. This might indicate extensive sharing of antigenic determinants
between epidermis and micro-organisms.
In view of the above observations it is possible to speculate that a number of the immune
dermatoses could he brought ahout or he maintained by environmental micro-organisms.
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The aetiology of psoriasis remains obscure, hut there are two main hypotheses as regards its
pathogenesis:' the epidermal hyperplasia is primary and the dermal inflammatory changes are
secondary; the epidermal hyperplasia is secondary. The flrst hypothesis was supported by
studies performed by Van Scott and co-workers.^ Their results appeared to support the
hypothesis that psoriasis is a genetically determined condition inherent to keratinocytes and this
resulted in research into the proliferative properties (cell cycle time), the course of cell
differentiation (keratin markers) and the aberrant metabolism (cAMP and cGMP contents) of
the 'psoriatic' keratinocyte. The flndings included the results that keratinocytes from psoriasis
lesions produce increased amounts of the mediators of inflammation, particularly leukotriene B4
(LTB4) and i2-hydroxyeicosatetraenoic acid (12HETE), which are also chemotactic factors for
myeloid cells and would explain the presence of cells of the non-speciflc immune system.
(PMNs, monoeytes) in the inflammatory inflltrate.
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The second hypothesis postulates that the epidermal lesions in psoriasis are secondary to a
primary immimological inflammation in the skin. When monoclonal antibodies (MAb) became
available the immunopathology of psoriasis was studied further and it was found that the
inflammatory inflltrate in the earliest lesions consisted mainly of CD4+ (inducer/helper) T
lymphocytes and monocytes, whereas polymorphonuclear cells were absent. Moreover, T
lymphocytes were also present in the epidermis where they were arranged closely to HLA-DR+
dendritic cells. Such an immunohistological pattern might also be consistent with a type IV
allergic reaction. The efficacy of cyclosporin A in psoriasis indicated an involvement of T
lymphocytes in maintaining activity and that they play a key role in the pathogenesis of
psoriasis.^"^ T lymphocytes from patients with psoriasis were stimulated to proliferate by
autologous epidermal cells. This reaction was described as the mixed epidermal cell-T
lymphocyte reaction (MECLR). We have confirmed this reaction and investigated the role of
epidermal and peripheral blood antigen-presenting cells in the process. In our in vitro system
the strength of the autologous MECLR proved to be dependent on the dose of epidermal cells
administered. The autologous MECLR proved to be a HLA-DR-restricted process. This
reaction was induced, not by peripheral blood antigen-presenting cells but by epidermal cells.
In the autologous MECLR the epidermal Langerhans cell did not play the crucial role as
observed in allergic contact reactions, as elimination of these cells from the epidermal cell
suspension led to merely a slight decrease in the proliferative response. Elimination of the other
HLA-DR+ cells from the epidermal cell suspension led to a virtually complete inhibition of the
response. The above results were used to produce a pathogenetic model in which both
hypotheses function. HLA-DR + dendritic epidermal cells present the 'psoriasis antigen' to
T lymphocytes. T lymphocytes become activated in the dermis, proliferate and produce
lymphokines (e.g. IL-2 and IFN-y). In response to the locally produced cytokines, keratino-
cytes and/or flbroblasts are likewise activated and proliferate. Due to genetically determined
factors, these keratinocytes and/or fibroblasts show an increased response to cytokines produced
by T lymphocytes. The production of an autocrine growth factor is thereby induced in
keratinocytes and/or fibroblasts. Alternatively, there is no negative feedback system for T
lymphocyte-induced proliferation in the psoriatic keratinocytes and/or fibroblasts. The two
original hypotheses are suggested to be interdependent.
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